News
We came across a bullish thesis on Novo Nordisk A/S (NVO) on Substack by Kontra Investments. In this article, we will ...
5h
Axios on MSNExclusive: Oikos adds protein shakes geared to GLP-1 usersHigh-protein yogurt brand Oikos is expanding beyond the dairy aisle with protein shakes geared to GLP-1 users, Danone North ...
A new study found users of one drug lost almost 50 percent more weight that users of Wegovy. People taking Eli Lilly’s ...
CVS Caremark decided to stop offering one product in favor of another for weight loss, the latest example of ...
A new study has found that people taking Eli Lilly's obesity drug Zepbound lost almost 50% more weight than those using Novo ...
The trends worry health experts, who say the medicines have potential to narrow differences in obesity rates among ...
Clinical trial participants who took tirzepatide, the drug sold as Zepbound, lost an average of 50 pounds over 72 weeks, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results